Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay  Roza Bidshahri,

Slides:



Advertisements
Similar presentations
RainDrop assay using 4 μL of genomic DNA Concentration of amplifiable DNA ≥ 50 ng? Copies/assay ≥ 10? T790M positive T790M negative reRainDrop assay using.
Advertisements

A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
Detection of Exon 12 Mutations in the JAK2 Gene
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Mutant Enrichment with 3′-Modified Oligonucleotides
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Carol Beadling, Tanaya L. Neff, Michael C
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Volume 135, Issue 2, Pages e7 (August 2008)
Todd S. Laughlin, Michael W. Becker, Jane L. Liesveld, Deborah A
One-Step Ligation on RNA Amplification for the Detection of Point Mutations  Lei Zhang, Jingjing Wang, Mia Coetzer, Stephanie Angione, Rami Kantor, Anubhav.
Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction  Karen S. Gustafson  The Journal.
Emily M. Kudalkar, Naif A. M
Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons 
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe–Based Single-
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
Bongyong Lee, Joseph Mazar, Muhammad N
High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants.
Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion, Niels M
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations  Nuria Mencia-Trinchant,
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin- Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens  Andrew.
MethySYBR, a Novel Quantitative PCR Assay for the Dual Analysis of DNA Methylation and CpG Methylation Density  Pang-Kuo Lo, Hanano Watanabe, Pi-Chun.
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications  Vera Grossmann, Andreas Roller, Hans-Ulrich Klein, Sandra Weissmann,
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Clinical Application of Picodroplet Digital PCR Technology for Rapid Detection of EGFR T790M in Next-Generation Sequencing Libraries and DNA from Limited.
Elena Castellanos-Rizaldos, Cloud Paweletz, Chen Song, Geoffrey R
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
B-Cell Clonality Determination Using an Immunoglobulin κ Light Chain Polymerase Chain Reaction Method  Reetesh K. Pai, Artemis E. Chakerian, John M. Binder,
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Quantitative Expression Profiling in Formalin-Fixed Paraffin-Embedded Samples by Affymetrix Microarrays  Diana Abdueva, Michele Wing, Betty Schaub, Timothy.
A Novel Targeted Approach for Noninvasive Detection of Paternally Inherited Mutations in Maternal Plasma  Jessica M.E. van den Oever, Ivonne J.H.M. van.
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Accurate Quantification of T Cells by Measuring Loss of Germline T-Cell Receptor Loci with Generic Single Duplex Droplet Digital PCR Assays  Willem H.
Hou-Sung Jung, Gregory J. Tsongalis, Joel A. Lefferts 
DNA Diagnostics by Surface-Bound Melt-Curve Reactions
Long-Range (17.7 kb) Allele-Specific Polymerase Chain Reaction Method for Direct Haplotyping of R117H and IVS-8 Mutations of the Cystic Fibrosis Transmembrane.
Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
Andrea Gaedigk, Amanda K. Riffel, J. Steven Leeder 
Multiplexed Detection of Anthrax-Related Toxin Genes
Hillary S. Sloane, James P. Landers, Kimberly A. Kelly 
Detection of Exon 12 Mutations in the JAK2 Gene
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin- Embedded Cutaneous Melanomas  Johanne Lade-Keller, Kirsten M. Rømer, Per.
Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer  Kazimierz.
Olivier Gruselle, Thierry Coche, Jamila Louahed 
KRAS Mutation The Journal of Molecular Diagnostics
Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay  Kathleen.
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell.
Ashleigh C. McEvoy, Benjamin A. Wood, Nima M. Ardakani, Michelle R
Efficient and Highly Sensitive Screen for Myotonic Dystrophy Type 1 Using a One-Step Triplet-Primed PCR and Melting Curve Assay  Mulias Lian, Indhu-Shree.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pediatric Low-Grade Gliomas  Yongji Tian, Benjamin E. Rich, Natalie.
Development of an Allele-Specific Real-Time PCR Assay for Discrimination and Quantification of p63 R279H Mutation in EEC Syndrome  Vanessa Barbaro, Letizia.
Low Incidence of Minor BRAF V600 Mutation-Positive Subclones in Primary and Metastatic Melanoma Determined by Sensitive and Quantitative Real-Time PCR 
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors  Martin Pichler, Marija Balic,
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
Two Novel Methods for Rapid Detection and Quantification of DNMT3A R882 Mutations in Acute Myeloid Leukemia  Melissa Mancini, Syed Khizer Hasan, Tiziana.
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
HPV Genotype Detection Using Hybrid Capture Sample Preparation Combined with Whole Genome Amplification and Multiplex Detection with Luminex XMAP  Brian.
Quantification of bcl-2/JH Fusion Sequences and a Control Gene by Multiplex Real- Time PCR Coupled with Automated Amplicon Sizing by Capillary Electrophoresis 
Presentation transcript:

Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay  Roza Bidshahri, Dean Attali, Kareem Fakhfakh, Kelly McNeil, Aly Karsan, Jennifer R. Won, Robert Wolber, Jennifer Bryan, Curtis Hughesman, Charles Haynes  The Journal of Molecular Diagnostics  Volume 18, Issue 2, Pages 190-204 (March 2016) DOI: 10.1016/j.jmoldx.2015.09.003 Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 BRAF V600 status assay automated data analysis overview. A: Representative output data for the WT-negative portion (well) of the assay are visualized in a two-dimensional scatter plot. B and C: Empty droplets (marked as gray dots) are identified by fitting to the FAM channel signal two normal distributions, one of low mean intensity (B) and the other of high mean intensity (C). All droplets (B) below a threshold FAM intensity (black line) set at the mean of the lower-intensity distribution plus 7 SDs are deemed empty and removed from the analysis. All filled droplets are then identified (C) as lying within the means ± 3 SDs of the upper distribution (gray band). D: Droplets displaying FAM intensities outside this range (often referred to as digital PCR rain) are taken as being poor in signal quality and excluded from the analysis. E: BRAF V600 WT− and WT+ droplets, respectively, are identified by fitting two normal distributions to the HEX channel signal, with the relevant populations bound by the means ± 3 SDs in each case. The distribution having the lower mean HEX intensity contains the population of WT-negative droplets. F: Analysis of the original data in A defines the populations of WT− (left gray box) and WT+ (right gray box) droplets, from which the mutant frequency is calculated as the ratio of WT− droplets to total droplets (ie, 195/(195 + 426) × 100 = 31.4%). Arb, arbitrary; FAM, 6-carboxyfluorescein; HEX, hexachloro-fluorescein; WT, wild-type. The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Schematic of the ddPCR BRAF V600 status assay for identifying WT, V600E1, and less common BRAF V600 MT alleles in CRC tumor samples. Water-in-oil emulsion droplets are generated to contain digital PCR mix and a small aliquot of genomic DNA that contains, on average 0.2 to 0.4 CPD BRAF allele(s). The two-well assay uses forward and reverse primers that amplify a 165-bp fragment of the BRAF gene that spans codon V600. Two dual-labeled hydrolysis probes that span BRAF codons 598 to 603 are used. A: The first, used in well 1, is a HEX-labeled LNA-substituted probe designed to selectively hybridize and unequivocally detect BRAFV600E1 by showing no cross-reactivity to other clinically relevant BRAF alleles. B: The second, used in well 2, is a FAM-labeled probe designed to hybridize only to WT BRAF and thereby distinguish WT V600 from all BRAF V600 MT alleles. A consensus probe that binds to a highly conserved sequence within the BRAF amplification template is also added to each reaction well. With the use of well 2 as an illustration of assay mechanics, when a BRAF V600 WT allele (upper duplex of B) is amplified, end-point fluorescence signals from the WT-specific probe (green) and the consensus probe (blue) are both detected. Amplification of any BRAF V600 MT allele (lower duplex of B) results in the generation of an end-point signal from the consensus probe only. In the resulting ddPCR two-dimensional plot (output data), droplets that contain amplicons of a V600 WT allele cluster in the FAM+/HEX+ quadrant (top right), whereas droplets that contain those of V600 MT allele cluster in the FAM+/HEX− quadrant (top left). Droplets that contain no BRAF template cluster in the bottom left (FAM−/HEX−) quadrant. CPD, copies per droplet; CRC, colorectal cancer; ddPCR, droplet-digital PCR; FAM, 6-carboxyfluorescein; FP, forward primer; HEX, hexachloro-fluorescein; LNA, locked nucleic acid; MT, mutant; RP, revers primer; WT, wild-type. The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 General relation between the end-point fluorescence (squares; left y axis) and the fraction α of template bearing a dual-hydrolysis probe (triangles; right y axis) as a function of the PCR annealing temperature Ta. Data reported for end-point fluorescence monitoring of qPCR amplification of WT BRAF (plasmid; CT = 0.5 μmol/L) with the use of the LNA V600 WT-specific probe (Table 1). Data points represent mean values for triplicate runs at each Ta, with the size of the data points commensurate with the SD for the data point having the largest experimental error. HEX, hexachloro-fluorescein; LNA, locked nucleic acid; qPCR, quantitative real-time PCR; RFU, relative fluorescence unit; WT, wild-type. The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Influence of ΔTm value on the performance of the WT-negative component of the ddPCR BRAF V600 status assay (well 2). Overlay of two-dimensional data output for the WT-negative digital PCR assay (well 2) independently applied against WT BRAF and six clinically relevant BRAF V600 MT plasmid DNA samples. A: Pure-DNA V600 WT-specific probe: data clusters for assay applied against MT alleles merge with the corresponding data cluster for the WT allele as ΔTm decreases to values <7°C, as seen for BRAF V600E, V600A, and V600G. B: LNA V600 WT-specific probe: a ΔTm >7°C is achieved against every MT allele, resulting in complete segregation of the data cluster for WT BRAF from that for every clinically relevant V600 mutation. arb, arbitrary; ddPCR, droplet-digital PCR; FAM, 6-carboxyfluorescein; LNA, locked nucleic acid; MT, mutant; WT, wild-type. The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 5 A and B: Analytical sensitivity (LOD) of the WT-negative component of the ddPCR BRAF V600 status assay when applied to plasmid (A) and cell-line gDNA (B) standards. Measured MF and SD values are plotted versus expected MF for serial dilutions down to 0.01% MF. The dotted line is the LOB of the WT-negative component of the assay. Significant linear correlation (R2 ≥ 0.996; P < 0.0001) between the measured and expected MF is observed down to 0.05% MF. Replicates of BRAF V600 WT genomic DNA from the specified source (plasmid or cell line) were used to define mean false-positives (WT BRAF, solid horizontal line) and SDs, from which the 95% CI was determined and used to define the LOB − 0.008% MF for both systems. n = 24 for 0.01% to 0.1% MF data; n = 4 for MF > 0.1% data; n = 24 replicates of BRAF V600 WT gDNA. Statistically significant MF values can be obtained to an LOD of 0.05%. ddPCR, droplet-digital PCR; LOB, limit of blank; LOD, limit of detection; MF, mutant frequency; WT, wild-type. The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 6 ddPCR BRAF V600 status assay data, immunohistochemical VE1 staining assay data, and sequencing data for clinical CRC tissue samples. A cohort of MLH1-deficient tumors was analyzed. A: Representative sample (sample no. 1) (Supplemental Table S1) found to be V600 WT+ with the use of the ddPCR assay and V600E− with the use of VE1 antibody staining. B: Representative sample (no. 6) detected as BRAF V600E1 with the use of the ddPCR assay and V600E+ by VE1 staining. C: Sample (no. 24) detected as BRAF V600 WT negative by the ddPCR assay, while staining negative for V600E. Boxes indicate cluster borders used to compute droplet counts and reported mutant frequencies (A–C). D: Sanger sequence of gDNA of patient 24 shows a BRAF V600R mutation (red arrows indicate mutated nucleotides) in concordance with the ddPCR BRAF V600 status assay. n = 41 MLH1-deficient tumors. CRC, colorectal cancer; ddPCR, droplet-digital PCR; FAM, 6-carboxyfluorescein; HEX, hexachloro-fluorescein; MLH1, Mut L homologue-1; WT, wild-type. The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Supplemental Figure S1 BRAF V600 WT-negative screen (well 2) output when applied to HDx Reference FFPE standards. A–D: Automated analysis of the data yield mean mutant frequencies of 0.04% ± 0.04% for a 100% BRAF WT V600 FFPE reference standard (A), 0.43% ± 0.37% for a 0.8% BRAF V600K FFPE reference standard (B), 1.51% ± 0.47% for a 1.4% BRAF V600E FFPE reference standard (C), and 47.82% ± 1.28% for a 50% BRAF V600R FFPE reference standard (D). Values are expressed as mean ± SEM. n = 2 experiments conducted in duplicate. FAM, 6-carboxyfluorescein; FFPE, formalin-fixed, paraffin-embedded; HEX, hexachloro-fluorescein; WT, wild-type The Journal of Molecular Diagnostics 2016 18, 190-204DOI: (10.1016/j.jmoldx.2015.09.003) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions